Earnings PreviewAVTX
AVTX Heads Into Earnings With 30% Short Interest and a Crowded Borrow
Avalo Therapeutics reports on May 8 carrying one of the most contested short-interest profiles in small-cap biotech. The bear trade is substantial. Short interest has climbed to 30.7% of the free float — up 29% over…
1 min read
